Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future

SIMPLE SUMMARY: This review article details the progress of lung cancer treatments for a subtype known as non-small cell lung cancer with a special mutation of epidermal growth factor receptor (EGFR). In the following review article, we included the past trials that exclusively involved the chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalata, Walid, Jacob, Binil Mathew, Agbarya, Abed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392600/
https://www.ncbi.nlm.nih.gov/pubmed/34439273
http://dx.doi.org/10.3390/cancers13164119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392600/
https://www.ncbi.nlm.nih.gov/pubmed/34439273
http://dx.doi.org/10.3390/cancers13164119

Ejemplares similares